Biosyncaucho’s project objective is the development of high value added chemical products from renewable raw materials.
Biosyncaucho was incorporated (May 2015) with Tecnalia’s strategic vision and commitment in the field of energy and the environment.
TECNALIA Research & Innovation transferred the intangible assests and a cash contribution to a New Company “Biosyncaucho S.L.” (2015, May), owned by TECNALIA and a private equity fund, KEREON Partners.
The project was sponsored by the Omega Fund, managed by Tecnalia Ventures with the collaboration of Kereon Partners (private investment fund).
Biokemik is the commercial denomination of the new Business Unit.
Investors (financial)
Agents willing to support Biokemik as a growth, scalable high internationalization potential company (for equity).
Customers
Potencial customers willling to validate the biomolecules for single or multiple applications
Licensees
Companies willing to acquire a independent license for the biomolecules.
Industrial Partners
Investors willing to: (a) support the last mile of BD development, (b) scale-up and industrialize products (for equity).
Smart Capital
Agents of any link in the value chain and new business models: Access to channels and final customers, Engineering, Catalyst experts and companies willing to add value to their Waste/Sub/Co-products providing raw materials.
Samples Request
Green Chemicals (Bio-1,3-Butadiene, Bio-2,3-Butanediol, Bio-Acetoin, Bio-Methyl-Ethyl-Ketone)
The company is integrated by an experienced Team, who has successfully developed and launched a number of spin-offs.
MSc. Jesús TorrecillaPresident of the Board of Directors, Biokemik
Master in Sciences, Univ. of Basque Country (Spain). Commercialization Director, Tecnalia. Tech. Transfer (6), Licensing (5) Startup funding (5)
Dr. José Ramón OchoaScientific Advisor
Chemistry PhD, Univ. of Basque Country, MBA (IE Business School) (Spain). Principal Researcher, Tecnalia. Books (1), Patents (26), Publications (80).
Mr. José TesánBoard Member
Civil Engineer, Univ. of Basque Country (Spain). Business Development, Kereon Partners.
Dr. Francisca Río
Senior Research Scientist, Biokemik
Chemistry PhD, Univ. of Basque Country (Spain). Senior Research Scientist, Tecnalia. Publications (15), Patents (5).
Dr. Walter RamírezBusiness Development Director, Biokemik
Doctor in Sciences, Université Lyon-I (France). Founder of Innventik S.L. Global Technology Director, Dynasol. NewTech. (15), Pat.(4), Public. (25), Spin-offs (4).
Dr. Tomás Roncal
Biotechnology Expert
Chemistry PhD, Univ. of Basque Country (Spain). Senior Research Scientist, Tecnalia. Publications (27), Patents (7).
Process
Biokemik’s technology to obtain Bio-chemicals via proprietary fermentation, chemical and separation processes, is protected via Patents and Patent Applications..
CECT microorganisms (Biological Risk 1) developed for high selectivity and activity, using cheap, accessible, non-alimentary raw materials, are registered.
The technology is protected by seven patent family applications (one of them granted) and three CECT registered microorganisms.
2012
ES2352633 (B8)
Cepa mutante de Lactococcus lactis lactis y método para la producción industrial de acetoína. Priority date: 2009-08-04 Publication date: 2012-02-20
2014
WO2016012634 (A1)
Method for manufacturing 2,3-Butanediol. ( 2,3-Butanediol by hydrogenation of 3-hydroxybutanone) (Priority date: 2014-07-23) Extended: EP, US, KR, CN, JP)
2015
WO2016097122 (A1)
Method for manufacturing 2,3-Butanediol. ( 2,3-Butanediol by electroreduction of 3-hydroxibutanone). (Priority date: 2015-12-17) Extended: EP, US, CN, JP)
2015
WO2016142419 (A1)
Metabolite production by lactic acid bacterium . (Priority date: 2015-03-09)
2016
PCT/EP/2017/068117
Bacterial Strain producing 2,3-Butanediol and other metabolites. (Priority date: 2016-07-19)
2016
PCT/EP2017/073021
Electrochemical method for manufacturing methyl ethyl ketone (Priority date: 2016-09-14)
2017
EP17382756
Method for continuous production of 2,3-Butanediol.
( 2,3-Butanediol by hydrogenation of 3-hydroxybutanone) (Priority date: 2017-11-19)